ArticleEating disorders2025
Early intervention for eating disorders: a call to action for inclusion of minoritized groups.
Article in Eating disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Do new labels solve old problems? Conceptual, ethical, and clinical challenges of constructing restrictive eating behaviours as "self-harm".Journal of eating disorders · 2026Article
- Feasibility and clinical outcomes of tailored digital CBT-E guided self-help for youth with binge-eating symptoms: A pilot randomized controlled trial.Internet interventions · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Eating disorders (EDs) are prevalent mental health conditions that occur globally and affect all population subgroups. Despite their severity and widespread impact, EDs are frequently underdiagnosed and undertreated, particularly among individuals from minoritized racial and ethnic backgrounds, and groups that have been historically excluded from ED research. Early intervention (EI) has been shown to improve outcomes by reducing untreated illness duration, yet its implementation remains limited. This commentary examines patient-, clinician-, and systemic-level barriers to the timely detection and treatment of EDs, with an emphasis on how these barriers impact individuals from minoritized backgrounds. Evidence-based strategies to improve access to EI are also discussed as pathways to more equitable and effective care. Increasing access to EI and culturally informed treatments is essential to mitigating the burden of EDs and improving outcomes across populations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.